Friday, 01 July 2022



LATEST NEWS Kangana Ranaut Takes Jibe At Uddhav Thackery's Resignation. Says, ‘When Sin Increases, There Is Destruction’ The Gita does not belong to a single religion, it is a book giving the essence of humanity to the whole world : Dr. Mohan Bhagwat Statue of Viraat Swaroop of Lord Krishna unveiled in Jyotisar, Kurukshetra Shrimad Bhagavad Gita is scripture of all religions : Bandaru Dattatraya NASA’s James Webb Telescope To Release “Deepest Image Of Universe Ever” ENG v IND, 5th Test : Jasprit Bumrah to lead India in Edgbaston Test, Rishabh Pant to be his deputy Shireen Mirza gets candid about her negative role in 'Bohot Pyaar Karte Hai' Nia Sharma's new music video 'Paisa Paisa' is out Goalkeeper Arshdeep Singh signs two-year contract with FC Goa Shiv Sena faction leader Eknath Shinde to be CM, Devendra Fadnavis to stay out James Anderson returns, Sam Billings retains place in England's playing eleven for Edgbaston Test Vidyut Jammwal fainted while shooting for 'Khuda Haafiz: Chapter 2-Agni Pariksha' Milind Soman returns to music videos after 25 years with 'Shringaar' Ashok Gehlot meets Kanhaiya Lal's family, assures strict punishment for accused Dozens buried alive in massive Manipur landslide; rescue on Eknath Shinde to be new Maharashtra Chief Minister : Devendra Fadnavis Chick-flick 'The Patolas' gets its second season MS Dhoni, Eoin Morgan are very calm; nothing fazes them on or off the field : Moeen Ali Sanya Malhotra opens up on working with Rajkummar Rao in 'HIT: The First Case' Mayawati finds UP bypoll result 'encouraging' 'Taarak Mehta Ka Ooltah Chashmah' gets new 'Nattu Kaka'


Scientists develop new combo treatment for head and neck cancer

Health, Study, Jerusalem, Research, Researchers, World News

Web Admin

Web Admin

5 Dariya News

Jerusalem , 28 Mar 2022

An Israeli-led research team has developed a potential new treatment for head and neck cancer (HNC), using a targeted drug and immunotherapy, Ben Gurion University (BGU) in southern Israel has announced. The findings, co-authored by Israeli, Chinese, French, German and US researchers, were published in the Journal for ImmunoTherapy of Cancer on Sunday, Xinhua news agency reported. Through pre-clinical study, the researchers found a new treatment combination of Trametinib, a cancer drug that brings a type of killer white blood cells to the cancer site, and Anti-PD-1, an immunotherapy that not kills cancer cells directly but blocks a pathway on immune cells to make them more engaged in fighting tumors.

In traditional clinical treatment, Trametinib has not shown efficiency in inhibiting the targetted hyper-active pathway of cancer cells, said the research. Researchers then analysed tumor-host interaction that facilitates immune escape in tumor-bearing mice, and found that using a short Trametinib treatment can make resistant tumors more sensitive to anti-PD-1 immunotherapy. "We sincerely hope that oncologists will test this treatment combination in HNC patients, as improving immunotherapy efficacy is crucial for prolonging the survival of cancer patients," the study's correspondent author Moshe Elkabets was quoted by the BGU statement as saying.


Tags: Health , Study , Jerusalem , Research , Researchers , World News



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD